 GENEVA, Switzerland May 1 2 , 2022 ObsEva SA NASDAQ: OBSV; SIX: OBSN, a biopharmaceutical company developing and commercializing novel therapies for womens health, today announced that it plans to host a conference call on Tuesday, May 17, 2022, at 8:00 a.m. ET to discuss its financial results for the quarter ended March 31, 2022 and provide a business update. 